Stay updated on Lintuzumab in CLAG-M for AML Clinical Trial

Sign up to get notified when there's something new on the Lintuzumab in CLAG-M for AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lintuzumab in CLAG-M for AML Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    The website footer now displays revision v3.8.0 instead of v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-31T14:29:27.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    A sitewide NIH notice announces a transition from using “Artificial Intelligence” to “Super Intelligence” terminology and links to updates and FAQs.
    Difference
    0.7%
    Check dated 2026-10-24T15:09:33.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The displayed ClinicalTrials.gov site revision changed from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-17T14:58:12.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The site release identifier in the footer was updated from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-10T15:09:29.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    A new revision entry labeled v3.7.0 was added to the record history, indicating the study record has been updated. This reflects the latest changes made to the study’s registration information.
    Difference
    0.1%
    Check dated 2026-09-19T19:08:14.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    The history now includes a new revision entry 'Revision: v3.6.6' added to the list, replacing 'Revision: v3.6.5'. This reflects a recent platform update captured in the record history.
    Difference
    0.1%
    Check dated 2026-08-29T18:18:27.000Z thumbnail image

Stay in the know with updates to Lintuzumab in CLAG-M for AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lintuzumab in CLAG-M for AML Clinical Trial page.